SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Meanwhile, semaglutide remains on the shortages list, but Novo Nordisk hopes it won’t be for long. The company last week noted that the last remaining dose in short supply, the lowest dose of ...

While semaglutide remains on the shortage list, Novo Nordisk noted last week that the last remaining dose in short supply -- the lowest dose of Wegovy -- is now listed as available, CNN reported.

The topline results from the ESSENCE trial of semaglutide showed that a once-weekly 2.4mg dose of the drug was better than placebo at resolving MASH and improving liver fibrosis, meeting its ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

"This model has the potential to deliver on the promise of transforming precision medicine for patients being treated with semaglutide," said Matthew Levy, Ph.D., senior research scientist at Helix.

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration ... Seven retrospective chart reviews (ie, case series) and 33 case ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Semaglutide, the active ingredient doing all the work ... but it’s something to consider if you’re not yet certain about the ...